Asia's Biopharma Boom: Thermo Fisher Fuels the Fire with Expanded Design Centers
The biopharmaceutical industry is exploding in Asia, driven by a surging demand for life-saving biologics, vaccines, and cutting-edge cell and gene therapies. But here's where it gets exciting: Thermo Fisher Scientific, a global leader in scientific solutions, is doubling down on this growth with a major expansion of its Bioprocess Design Centers across the region. This isn't just about building bigger labs; it's about bringing world-class expertise, cutting-edge technology, and localized support directly to the heart of Asia's biopharma revolution.
December 2, 2025 marks a significant milestone as Thermo Fisher unveils a brand-new Bioprocess Design Center in Hyderabad, India, and expands its existing hubs in Incheon, Korea, and Singapore. This strategic tri-hub network isn't just about physical space; it's a powerful engine designed to accelerate innovation, streamline biomanufacturing processes, and ultimately, get life-changing therapies to patients faster and more sustainably.
Why Asia? The continent is rapidly becoming a global hub for biopharma innovation. And this is the part most people miss: Thermo Fisher's investment isn't just about capitalizing on this growth; it's about actively fueling it. By providing local access to their unparalleled expertise and technologies, they're empowering Asian biopharma companies to compete on a global scale.
Daniella Cramp, Senior Vice President and President, BioProduction at Thermo Fisher Scientific, highlights the significance: “Asia's role in driving biopharma innovation is undeniable. Our expanded network brings our world-class infrastructure and knowledge directly to our customers, enabling them to develop and deliver high-quality biologics with unprecedented speed, cost-effectiveness, and sustainability.”
A Network of Innovation:
Each of Thermo Fisher's Bioprocess Design Centers plays a unique role in this regional ecosystem:
Incheon, Korea: This expanded center fosters deeper collaboration and innovation through advanced materials, cutting-edge technologies, and enhanced lab capabilities, pushing the boundaries of bioprocessing.
Hyderabad, India (Genome Valley): Developed in partnership with the Government of Telangana, this new center offers collaborative spaces for process design, simulation, and optimization. It empowers customers to co-create and test bioprocesses using the latest single-use and hybrid systems, propelling India's burgeoning biomanufacturing sector forward.
Singapore: This expanded facility provides a comprehensive platform, from bench-to-pilot scale bioprocessing to expert-led training and close collaboration with Thermo Fisher's technical teams. This supports flexible and sustainable biomanufacturing, crucial for bringing new therapies to market swiftly.
From Lab to Patient: A Seamless Journey
Thermo Fisher's commitment goes beyond design centers. They offer a full spectrum of breakthrough technologies, from next-generation sequencing and mass spectrometry to advanced bioprocessing systems. Their end-to-end capabilities span the entire biopharma value chain, supporting customers from initial research to commercialization.
Tony Acciarito, President, Asia Pacific and Middle East, Africa at Thermo Fisher Scientific, emphasizes the impact: “Through strategic investments, partnerships, and cutting-edge manufacturing, we're redefining the possibilities of biologics production. We're proud to be a driving force in Asia's biopharma transformation, helping our customers deliver life-changing therapies to patients across the continent and beyond.”
The Future of Biopharma is Here
Thermo Fisher's expansion in Asia is more than just a business move; it's a testament to the region's potential as a global leader in biopharmaceutical innovation. By empowering local companies with the tools and expertise they need, Thermo Fisher is not only accelerating the development of life-saving therapies but also shaping the future of healthcare worldwide.
What does this mean for the future of healthcare? Will Asia become the dominant force in biopharma innovation? Share your thoughts in the comments below!
To learn more about Thermo Fisher's Bioprocess Design Centers, visit www.thermofisher.com/bdc.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $40 billion. Our mission is to enable our customers to make the world healthier, cleaner, and safer. We support researchers, clinicians, and manufacturers across diverse fields, from life sciences and diagnostics to analytical instruments and pharmaceutical services. Our global team delivers an unparalleled combination of innovative technologies, convenient purchasing options, and comprehensive pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. For more information, visit www.thermofisher.com.
